137 related articles for article (PubMed ID: 6812344)
1. Influence of nandrolondecanoate on the pituitary-gonadal axis in males.
Bijlsma JW; Duursma SA; Thijssen JH; Huber O
Acta Endocrinol (Copenh); 1982 Sep; 101(1):108-12. PubMed ID: 6812344
[TBL] [Abstract][Full Text] [Related]
2. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of androgen anabolic steroids and physical activity on the hypothalamic-pituitary-gonadal axis.
Hengevoss J; Piechotta M; Müller D; Hanft F; Parr MK; Schänzer W; Diel P
J Steroid Biochem Mol Biol; 2015 Jun; 150():86-96. PubMed ID: 25797375
[TBL] [Abstract][Full Text] [Related]
4. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
[TBL] [Abstract][Full Text] [Related]
5. Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism.
Bijlsma JW; Duursma SA; Bosch R; Huber O
Acta Endocrinol (Copenh); 1982 Sep; 101(1):140-3. PubMed ID: 7124288
[TBL] [Abstract][Full Text] [Related]
6. Effects of anabolic steroid (19-nortestosterone) on the secretion of testicular hormones in the stallion.
Nagata S; Kurosawa M; Mima K; Nambo Y; Fujii Y; Watanabe G; Taya K
J Reprod Fertil; 1999 Mar; 115(2):373-9. PubMed ID: 10434944
[TBL] [Abstract][Full Text] [Related]
7. Plasma oestrogens in postmenopausal women with endometrial cancer.
Nyholm HC; Nielsen AL; Lyndrup J; Dreisler A; Hagen C; Haug E
Br J Obstet Gynaecol; 1993 Dec; 100(12):1115-9. PubMed ID: 8297845
[TBL] [Abstract][Full Text] [Related]
8. Effect of exposure to long days on the secretion of oestradiol, oestrone, progesterone, testosterone, androstenedione, cortisol and follicle-stimulating hormone in intact and spayed ferrets.
Donovan BT; Matson C; Kilpatrick MJ
J Endocrinol; 1983 Dec; 99(3):361-8. PubMed ID: 6417256
[TBL] [Abstract][Full Text] [Related]
9. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
10. Endocrinological environment with regard to the number of microcysts in patients with polycystic ovary syndrome.
Yoshino K; Takahashi K; Eda Y; Okada S; Kitao M
Hum Reprod; 1992 Oct; 7(9):1201-4. PubMed ID: 1478997
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
12. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-gonadal axis, prolactin, and cortisol in alcoholics during withdrawal and after three weeks of abstinence: comparison with healthy control subjects.
Heinz A; Rommelspacher H; Gräf KJ; Kürten I; Otto M; Baumgartner A
Psychiatry Res; 1995 Jan; 56(1):81-95. PubMed ID: 7792345
[TBL] [Abstract][Full Text] [Related]
14. Paramethasone acetate (PA): corticosteroid potency vs hypothalamic pituitary-gonadal axis.
Cortés-Gallegos V; Alonso R; Castañeda G; Sojo I; Carranco A; Cervantes C; Parra A
J Steroid Biochem; 1984 Jan; 20(1):353-6. PubMed ID: 6423900
[TBL] [Abstract][Full Text] [Related]
15. Changes in the pituitary-testicular system with age.
Baker HW; Burger HG; de Kretser DM; Hudson B; O'Connor S; Wang C; Mirovics A; Court J; Dunlop M; Rennie GC
Clin Endocrinol (Oxf); 1976 Jul; 5(4):349-72. PubMed ID: 971543
[TBL] [Abstract][Full Text] [Related]
16. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
[TBL] [Abstract][Full Text] [Related]
17. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis.
Tsigos C; Papanicolaou DA; Kyrou I; Raptis SA; Chrousos GP
J Interferon Cytokine Res; 1999 Nov; 19(11):1271-6. PubMed ID: 10574620
[TBL] [Abstract][Full Text] [Related]
19. Physical health and fitness of an elite bodybuilder during 1 year of self-administration of testosterone and anabolic steroids: a case study.
Alén M; Häkkinen K
Int J Sports Med; 1985 Feb; 6(1):24-9. PubMed ID: 3921472
[TBL] [Abstract][Full Text] [Related]
20. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
